| Revenues |
During the three and six months ended June 30, 2026 and 2025, our revenues consisted of the following (in thousands):
| | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | June 30, | | June 30, | | | | 2026 | | | | 2025 | | | | 2026 | | | | 2025 | | | Revenue: | | | | | | | | | | | | | | | | | Commercial revenue: | | | | | | | | | | | | | | | | | Product sales, net: | | | | | | | | | | | | | | | | | TRYNGOLZA sales, net | $ | 4,574 | | | $ | 19,273 | | | $ | 31,674 | | | $ | 25,561 | | | DAWNZERA sales, net | | 26,565 | | | | - | | | | 42,420 | | | | - | | | Total product sales, net | | 31,139 | | | | 19,273 | | | | 74,094 | | | | 25,561 | | | Royalty revenue: | | | | | | | | | | | | | | | | | SPINRAZA royalties | | 53,486 | | | | 54,337 | | | | 97,196 | | | | 102,347 | | | WAINUA royalties | | 16,436 | | | | 10,415 | | | | 27,145 | | | | 19,787 | | | Other royalties | | 6,036 | | | | 5,200 | | | | 9,941 | | | | 11,983 | | | Total royalty revenue | | 75,958 | | | | 69,952 | | | | 134,282 | | | | 134,117 | | | Other commercial revenue | | 11,526 | | | | 13,531 | | | | 18,058 | | | | 19,246 | | | Total commercial revenue | | 118,623 | | | | 102,756 | | | | 226,434 | | | | 178,924 | | | Research and development revenue: | | | | | | | | | | | | | | | | | Collaborative agreement revenue | | 133,137 | | | | 336,921 | | | | 253,797 | | | | 381,951 | | | WAINUA joint development revenue | | 16,189 | | | | 12,372 | | | | 33,811 | | | | 22,785 | | | Total research and development revenue | | 149,326 | | | | 349,293 | | | | 287,608 | | | | 404,736 | | | Total revenue | $ | 267,949 | | | $ | 452,049 | | | $ | 514,042 | | | $ | 583,660 | |
|